Regular Inhaled Corticosteroids Use May Protect Against Severe COVID-19 Outcome in COPD

PURPOSE: Population-based studies provide conflicting evidence about how inhaled corticosteroids (ICS) impact COVID-19 outcomes among COPD patients. We investigated whether regular ICS exposure affects risk, severity, or survival in SARS-CoV-2 infection, using a nationwide linked Swedish population...

Descripción completa

Detalles Bibliográficos
Autores principales: Labor, Marina, Kirui, Brian K, Nyberg, Fredrik, Vanfleteren, Lowie E G W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10421743/
https://www.ncbi.nlm.nih.gov/pubmed/37576828
http://dx.doi.org/10.2147/COPD.S404913

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10421743/
https://www.ncbi.nlm.nih.gov/pubmed/37576828
http://dx.doi.org/10.2147/COPD.S404913

Ejemplares similares